Figure 3.
Combination of CRISPR/Cas9 and pluripotent stem cells to provide human organs from chimaeric pigs. Generation of human organs by producing multigene mutations of essential regulators of vascular and lymphatic tissues in the desired organ via rapid and efficient CRISPR/Cas9-mediated genome editing in concert with blastocyst complementation.